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MilkEvidence is provided from studies on natural and artiﬁcial bioﬂuids that the sequestration of amorphous
calcium phosphate by peptides or proteins to form nanocluster complexes is of general importance in the
control of physiological calciﬁcation. A naturally occurring mixture of osteopontin peptides was shown,
by light and neutron scattering, to form calcium phosphate nanoclusters with a core–shell structure. In
blood serum and stimulated saliva, an invariant calcium phosphate ion activity product was found which
corresponds closely in form and magnitude to the ion activity product observed in solutions of these oste-
opontin nanoclusters. This suggests that types of nanocluster complexes are present in these bioﬂuids as
well as in milk. Precipitation of amorphous calcium phosphate from artiﬁcial blood serum, urine and sal-
iva was determined as a function of pH and the concentration of osteopontin or casein phosphopeptides.
The position of the boundary between stability and precipitation was found to agree quantitatively with
the theory of nanocluster formation. Artiﬁcial bioﬂuids were prepared that closely matched their natural
counterparts in calcium and phosphate concentrations, pH, saturation, ionic strength and osmolality.
Such ﬂuids, stabilised by a low concentration of sequestering phosphopeptides, were found to be highly
stable and may have a number of beneﬁcial applications in medicine.
 2013 The Authors. Published by Elsevier Inc. All rights reserved.1. Introduction
Most mammalian bioﬂuids are supersaturated with respect to
the bone and tooth mineral hydroxyapatite (HA) (Glinkina et al.,
2004; Hay et al., 1982; Holt et al., 1981; Linder and Little, 1986;
May and Murray, 1991b; Tiselius et al., 2009). Nevertheless,
bioﬂuids that are in contact with soft tissues, especially those,
like milk, that must be stored for any length of time, should be
highly stable with respect to calcium phosphate precipitation.
In contrast, saliva and the extracellular matrix of hard tissues,especially near to sites of mineralisation or remineralisation, are
required not only to maintain the mineral phase with which they
are in contact but also to deposit calcium phosphate in a highly
controlled manner.
A supersaturated solution of calcium and phosphate does not
directly precipitate as crystalline hydroxyapatite under physiolog-
ical conditions (Johnsson and Nancollas, 1992; Posner and Betts,
1975; van Kemenade and de Bruyn, 1987). Instead, amorphous cal-
cium phosphate precursor phases (ACP-1 and ACP-2) are formed
(Christoffersen et al., 1990; Meyer and Eanes, 1978). These precip-
itated phases are transformed via a number of other intermediate
and more structured states until they eventually attain the ﬁnal,
most stable and least soluble, state of crystalline HA. However,
the prolonged existence of amorphous, nano-particulate or other
intermediate states is well established in calcium phosphate and
calcium carbonate mineralised tissues (Addadi et al., 2012; Beniash
et al., 2009; Lange et al., 2011; Mahamid et al., 2010; Nudelman
et al., 2010, 2012; Weiner and Addadi, 2011; Xie and Nancollas,
2010; Yang et al., 2010).
Phosphoproteins or phosphopeptides can affect all stages of
the in vitro precipitation and maturation process to either induce
heterogeneous nucleation or increase the lag time before
precipitation of a supersaturated solution, slow down the rate
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maturation of the amorphous and poorly crystalline phases
(Boskey et al., 2010; George and Veis, 2008; Gericke et al.,
2005b; Hunter et al., 2010; Wang and Nancollas, 2009). At low
concentration, or when bound to the collagen matrix in bone or
dentine, phosphoproteins such as bone sialoprotein or phospho-
phoryn can facilitate nucleation and oriented growth of the min-
eral phase at speciﬁc sites (Baht et al., 2008; Hunter and
Goldberg, 1993; Ito et al., 2004). Thus, some secreted phospho-
proteins can act as either an inhibitor or a promoter of phase sep-
aration from a supersaturated solution, depending on their
concentration, pattern of phosphorylation, post secretory proteo-
lytic processing and the amount of ACP that could form (Boskey
et al., 2010; George and Veis, 2008; Gericke et al., 2010; Holt,
2013; Prasad et al., 2010; Rodriguez et al., 2013).
Certain phosphoproteins, including caseins, fetuin-A and oste-
opontin (OPN), if present at a sufﬁciently high concentration, can
form metastable (Jahnen-Dechent et al., 2011; Wald et al.,
2011a,b) or even equilibrium complexes (Holt et al., 2009; Little
and Holt, 2004) with ACP, so that precipitation of a bulk phase
is delayed or prevented altogether. Equilibrium complexes have
been made with unfolded and ﬂexible phosphoproteins that con-
tain one or more phosphate centres. A phosphate centre is a short
acidic sub-sequence in which three or more residues are phos-
phorylated. A typical example from caseins is the sequence of
the single phosphate centre of bovine b-casein: -E-pS-L-pS-pS-
pS-E-E-, where pS is a phosphoseryl residue. Other examples in-
clude sequences in osteopontin and other phosphoproteins from
mineralised tissues (Holt et al., 2009) including the extrapallial
protein orchestin (Hecker et al., 2004). The non-phosphorylated
acidic residues in phosphate centres and their ﬂanking sequences
may also inﬂuence the strength of binding. The effect of adding
Asp residues to a phosphate centre was explored by recombinant
methods applied to casein-like sequences (Clegg and Holt, 2009).
Sequences that are less highly phosphorylated than phosphate
centres as well as unphosphorylated acidic sequences can, for
example, bind to crystalline calcium phosphates or inhibit the
maturation of ACP (George and Veis, 2008) but they have not,
so far, been demonstrated to form the equilibrium nanocluster
complexes.
The equilibrium nature of the complexes has been demon-
strated most convincingly by forming the complexes by either
a ‘‘forward’’ reaction from a supersaturated solution containing
an excess of the phosphopeptide or from a ‘‘back’’ reaction in
which the phosphopeptide is added to a freshly formed precipi-
tate of ACP. Whether formed from the ‘‘forward’’ or the ‘‘back’’
reaction, the complexes have the same equilibrium size and
composition.
In this paper, experimental observations and some generally
accepted ideas on phase separation from supersaturated calcium
phosphate solutions are used to describe the stability of bioﬂ-
uids and the extracellular matrix in soft and hard tissues. It is
suggested that the formation of stable complexes between
phosphopeptides and ACP allows most bioﬂuids to be stable
near to their physiological pH even though they remain super-
saturated with respect to the mineral phase of bones and teeth
(Holt, 2013). As a result, soft and hard tissues can co-exist in
the same organism with relative ease. The hypothesis is tested
experimentally by exploring the boundary between stability
and instability in artiﬁcial bioﬂuids simulating the continuous
phase in blood, urine and saliva and the results are compared
to previous ﬁndings on milk. In this context the continuous
phase is the solution of ions and small molecules in which pro-
teins, lipid droplets, proteins and cells are suspended or dis-
solved. Its composition is approximated by an ultraﬁltrate or
equilibrium diffusate.2. Materials and methods
2.1. Invariant ion activity product
The activities of ions in the natural and artiﬁcial bioﬂuids were
calculated from a model of the ion equilibria originally developed
and tested for milk (Holt et al., 1981) and validated by independent
groups (Mekmene et al., 2009; Rice et al., 2010). The model was
subsequently extended to the calculation of the interaction of cal-
cium ions with caseins or osteopontin and the formation of nanocl-
usters of sequestered ACP (Holt, 2004; Holt et al., 2009; Little and
Holt, 2004). The ACP forms the core of the nanocluster complex
and is surrounded by a shell of sequestering protein. The calcula-
tion of the extent of formation of the nanoclusters makes use of
the experimental observation that nanocluster solutions exhibit
an invariant ion activity product.
In classical thermodynamics, an equilibrium can be established
between a precipitated (solid) phase and the solution with which it
is in contact:
CaHPO4ðsÞ¡Ca2þðaqÞ þHPO24 ðaqÞCa3ðPO4Þ2ðsÞ¡3Ca2þðaqÞ þ 2PO24 ðaqÞ
The solubility of the solid phase is given by a solubility constant,
KS, which can be expressed as a product of the activities of the ions
in the solution. The form of the ion activity product depends on the
stoichiometry of the solid. For example, for a dicalcium phosphate,
Ca1(HPO4)1, the ion activity product can be expressed in the
form [Ca2+]1[HPO42]1, whereas that of a tricalcium phosphate,
Ca3(PO4)2, can take the form [Ca2+]3[PO43]2. The square brackets
around the ions denote their activity, which, for very dilute solu-
tions, is approximately equal to their concentration but for bioﬂ-
uids, the ion activities are normally signiﬁcantly smaller than
their concentrations. It should be noted that whereas the ion activ-
ity product always has the same value when the solution is at equi-
librium with the solid (i.e. it is invariant), the activities of the
individual ions can vary. These two examples illustrate the rela-
tionship between the stoichiometry of the chemical formula and
the form of the ion activity product. Conversely, the exponents of
the ion activities in an equation that gives an invariant ion activity
product reﬂect the molar ratios of the ions in the solid. Different
solid phases can have the same molar proportions of ions. For
example, there are two different crystalline tricalcium phosphates,
a and b and an amorphous tricalcium phosphate. Even though the
ion activity product of the three phases takes the same form, their
magnitudes are quite different and characteristic of each solid
phase.
These ideas can be extended from the formation of a macro-
scopic precipitate, or phase, to that of nanoscale particles provided
the size of the nanoparticle is constant (Holt et al., 2009). However,
the composition of the sequestered ACP and hence the form taken
by the ion activity product is expected to depend on the nature of
the sequestering phosphopeptide. For example, the ACP seques-
tered by casein phosphopeptides is more acidic than the amor-
phous tricalcium phosphate sequestered by OPN 1-149 (Holt
et al., 2009; Little and Holt, 2004).
In previous work the form and magnitude of invariant ion activ-
ity products were determined in bovine, caprine and human milks
and in solutions containing amorphous calcium phosphates
sequestered by casein or osteopontin peptides (Cross et al., 2005;
Holt, 1982, 1993, 2004; Holt et al., 1981, 1994; Holt et al., 2009;
Little and Holt, 2004). In all these examples the presence of a
sequestered form of amorphous calcium phosphate is well estab-
lished. In this work we provide strong evidence that blood serum
and stimulated saliva also contain a sequestered form of
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invariant ion activity product with the same form and a very sim-
ilar magnitude to that found in solutions of osteopontin nanoclus-
ters. The invariant ion activity product is an intrinsic
thermodynamic parameter which therefore does not depend on
the concentration of sequestered ACP. Conversely, if an invariant
ion activity product for sequestered ACP is found in a large number
of samples of a bioﬂuid covering a wide variation in composition
then it may be reasonably concluded that sequestered ACP is nor-
mally present in the bioﬂuid, albeit possibly at a very low
concentration.
2.2. Calculation of ion equilibria
Bioﬂuids contain large numbers of components, many of which
interact. To fully understand these equilibria, computer models of
various degrees of sophistication have been described. For exam-
ple, models of the ion equilibria in blood plasma (Glinkina et al.,
2004; Kokubo et al., 1990; May et al., 1977; Silwood et al., 2002),
bovine, caprine and human milk sera (Holt, 1993; Holt et al.,
1981; Mekmene et al., 2010; Ormrod et al., 1982; Rice et al.,
2010), human urine (Brown et al., 1994; Linder and Little, 1986;
Marangella et al., 1985; Pak et al., 2004; Robertson et al., 1968;
Tiselius et al., 2009) and human saliva (Grøn, 1973a; Larsen and
Pearce, 2003; Silwood et al., 2002). The models allow the activities
of ions to be determined and from these the ion activity products
of different solid phases can be calculated. It is invariably found
that all physiological ﬂuids are supersaturated with respect to
hydroxyapatite (c.f. Table 1). Particular bioﬂuids such as urine
are sometimes supersaturated with respect to other salts and
may form urinary stones. A widely used model of the ion equilibria
in urine is implemented in the computer program EQUIL93 and its
predecessors (Brown et al., 1994). It helped to clarify the state of
supersaturation of urine with respect to uric acid, calcium oxalates
and calcium phosphates. The computer program JESS (Joint Expert
Speciation System) (May and Murray, 1991a,b) has also been ap-
plied to urine (Rodgers et al., 2006; Tiselius et al., 2009) and blood
serum (May et al., 1977). It uses a larger number of chemical equi-
libria than other speciation programs and produces better corre-
spondence than EQUIL93 between the predicted saturation and
measured solubility of calcium oxalates in urine (Pak et al., 2004,
2009). A notable feature of JESS speciation calculations for cit-
rate-rich bioﬂuids such as urine and milk is the inclusion of ternary
complexes between calcium, citrate and a third ligand such as
phosphate. However, the evidence of such complexes is weak
(Ramamoorthy and Manning, 1975) and has been questioned
(Berthon, 1995). For this reason, the ternary complexes were not
included in the ion equilibria used here.Table 1
Salt composition (mM), ionic strength, free ion concentrations and state of saturation
of human artiﬁcial urine and ultraﬁltrates of serum, saliva and milk.
Serum Urine Saliva Milk
Calcium 1.8 4.1 0.8 7.3
Magnesium 0.6 2.9 – 0.9
Sodium 144.9 148.4 31.6 2.2
Potassium 4.4 42.0 31.0 13.3
Pi 1.0 20.5 2.5 2.2
Chloride 151.8 177.4 58.0 24.1
Citrate – 2.3 – 2.1
pH 7.4 5.9 7.35 6.8
Ionic strength 150.0 187.0 65.6 35.3
Ca2+ 1.1 1.8 0.5 4.7
Mg2+ 0.4 1.4 – 0.6
Log S (ACP-2) 1.40 1.54 1.53 2.56
Log S (HA) 7.73 3.77 7.85 10.02The metastable supersaturated state of physiological bioﬂuids is
widely but not universally accepted. Ashby and Györy (Ashby and
Györy, 1997; Ashby et al., 1999; Györy and Ashby, 1999) have pro-
posed that in urine there is a state of thermodynamic equilibrium
between the continuous phase and crystals of various solid phases,
including HA. The solid phases are not easily detected because they
are supposed to be ﬁnely dispersed. Their calculations have been
implemented in the computer program SEQUIL (Ashby et al.,
1999). According to these authors, the crucial difference between
a normal urine and crystalluria is only the size of the crystals.
Kavanagh (Kavanagh, 2001) has criticised this equilibrium model
principally because the supposed dispersed crystals, which would
need to be abundant, have never been detected in the required
quantity (Politi et al., 1989; Sheinfeld et al., 1978). According to
Kavanagh (Kavanagh, 2001), the evidence cited by Ashby and
Györy in favour of their equilibrium model is not decisive because
it is also capable of interpretation by the usual model of a supersat-
urated solution.
The reason why bioﬂuids do not immediately precipitate cal-
cium phosphate is commonly thought to be because of inhibitors
of precipitation such as Mg2+, citrate, pyrophosphate and, most
powerfully, certain secreted phosphoproteins (Bisaz et al., 1978;
Fleisch, 1981; Hay, 1995; Hay et al., 1979; Rufenacht and Fleisch,
1984; Spielman et al., 1991). Examples of inhibitory phosphopep-
tides include OPN phosphopeptides in virtually all bioﬂuids, stath-
erin and the basic and acidic proline-rich phosphopeptides in
saliva, fetuin-A, secreted phosphoprotein 24 and OPN in blood
and uropontin, an isoform of OPN, in urine.
The models of ion speciation implemented in the programs
JESS, EQUIL and SEQUIL do not describe the equilibria between
small ions and proteins. Since there is overwhelming evidence of
the importance of such interactions, the present study used a com-
puter model that also used experimental data on the binding of
calcium and magnesium ions to a casein phosphate centre as a
function of pH and the free ion concentrations. The same model
was previously used to calculate the partition of salts in bovine
milk into ultraﬁlterable and non-ultraﬁlterable fractions and to
make similar calculations in casein nanocluster solutions T(Holt,
2004; Holt et al., 2009; Little and Holt, 2004). In modelling the
equilibria in OPN nanocluster solutions, a calcium ion binding iso-
therm for OPN 1-149 was measured at pH 7.0 and the binding at
other pH values was calculated from a model of the competition
between protons and calcium ions for the binding sites (Holt
et al., 2009).
In this work, the ion activity products for ACP sequestered by
casein or OPN phosphopeptides, ACP-2 and carbonate-free
hydroxyapatite were calculated only after allowing for the binding
of calcium ions to casein phosphate centres or to OPN 1-149.
Saturation indices (S) were obtained by dividing the ion activity
product by the corresponding thermodynamic solubility product
(Holt et al., 2009; Little and Holt, 2004; McDowell et al., 1977;
Meyer and Eanes, 1978). Undersaturated, saturated and supersatu-
rated solutions have S < 1, S = 1 and S > 1, respectively.
2.3. Artiﬁcial bioﬂuids
The artiﬁcial sera were designed to approximate the physiolog-
ically important properties of ionic strength, free phosphate, cal-
cium and magnesium ion concentrations and supersaturation
with respect to HA.
The artiﬁcial serum used in this work approximates the average
salt composition of blood plasma ultraﬁltrate (Walser, 1961, 1962).
The composition of the artiﬁcial human milk ultraﬁltrate
approximates the average salt composition of ultraﬁltrate from
milk after it has equilibrated with air (Holt, 1993). The artiﬁcial
urine was based on the salt composition of normal urine from
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Curhan, 2007). The artiﬁcial stimulated saliva was based on the
average salt composition of stimulated saliva ultraﬁltrate (Grøn,
1973a,b). Formulations were simpliﬁed by the omission of urate
and oxalate to avoid uric acid and calcium oxalate precipitation,
respectively, and bicarbonate to eliminate pH drift on equilibration
with air. Carbonate ion concentrations were not determined in the
artiﬁcial ﬂuids.
Table 1 shows the concentrations of the salt constituents of the
artiﬁcial bioﬂuids and some calculated properties.Fig. 1. Stabilisation of artiﬁcial serum against calcium phosphate precipitation by a
phosphate centre-containing phosphopeptide. The stability boundary was calcu-
lated using the serum composition of Table 1 and the solubility constant and
composition of OPNmix nanoclusters (Holt et al., 2009).2.4. Stability diagram of a bioﬂuid
The stability diagram of a bioﬂuid is a graph of the minimum
concentration of phosphate centres needed to suppress precipita-
tion of calcium phosphate plotted as a function of pH. Here we cal-
culate the theoretical stability diagram based on the quantitative
theory of ACP sequestration by a phosphate centre-containing
phosphopeptide. According to the theory, a solution is stable if it
contains a sufﬁciently high concentration of phosphate centres to
completely sequester the number of moles of ACP formed at
equilibrium. If this criterion is satisﬁed, the solution is thermody-
namically stable even though it remains supersaturated with
respect to HA.
The invariant ion activity product of the ACP nanocluster, KS,
can be used, along with the composition of the nanoclusters, to cal-
culate the extent of formation of the complexes (Little and Holt,
2004). The principles of the calculation can be brieﬂy stated as fol-
lows. From the given pH and the concentrations of salts and phos-
phate centres, the ion equilibria are evaluated as well as the
binding of calcium ions to the phosphopeptide with the assump-
tion that no nanoclusters are present. If the calculated ion activity
product in the solution is below KS then the solution is undersatu-
rated and stable. If the calculated ion activity product exceeds KS
then the concentration of nanoclusters in the calculation is gradu-
ally increased and the concentrations of calcium and phosphate in
the continuous phase decreased until the ion activity product in
the continuous phase equals the KS. The program then calculates
whether there is a sufﬁciently high concentration of phosphate
centres to make the nanoclusters. If there is, then the solution is
stable but if not the solution is unstable or, at best, metastable.
Appendix A explores an extension of the thermodynamic theory
of stability to deal with some other potential causes of metastabil-
ity or instability such as stabilisation by non-phosphate centre-
containing phosphopeptides, unphosphorylated peptides such as
poly-Asp and the effect of an incomplete shell of sequestering
phosphate centres.
An example calculation of the effect of pH on the artiﬁcial hu-
man serum described in Table 1 is shown in Fig. 1. The artiﬁcial
serum is stabilised by a phosphate centre-containing phosphopep-
tide. For most bioﬂuids, including all those considered here, there
is a critical pH, pHcrit, at which the calculated ion activity product
is equal to KS and the minimum concentration or activity of phos-
phate centres is zero ([PC]min = 0). Above pHcrit the nanocluster
complexes could form and [PC]min has to be increased to achieve
thermodynamic stability. A boundary line is formed by the calcu-
lated values of [PC]min as a function of pH. The [PC]min increases
with pH until a plateau is approached ([PC]plat), typically above
pH 8, where nearly all phosphate species are unprotonated and
much of the total Pi and calcium has been sequestered. Between
the calculated boundary and the abscissa is a region of instability
where there is insufﬁcient phosphopeptide to sequester all the
ACP produced. To the left of the calculated boundary is the single
phase region of stability. Close to the boundary line, in the unstable
region, is a band of metastability of undeﬁned width in whichprecipitation may be delayed for a variable period known as the
lag time.
2.5. Preparation of artiﬁcial bioﬂuids
Supersaturated artiﬁcial bioﬂuids were prepared to give the
compositions shown in Table 1. To prevent precipitation at the
physiological pH, a low phosphate centre concentration was intro-
duced, normally provided by phosphopeptides derived from either
OPN from bovine milk (OPNmix), the sodium salt of phosphopep-
tides derived from a tryptic digest of whole bovine casein (NaCPP)
(Ellegård et al., 1999) or the pure single peptide, residues 1–25 of
mature bovine b-casein (b-casein 1-25).
After secretion, phosphoproteins such as OPN are normally sub-
ject to further proteolytic processing by proteinases such as throm-
bin (Grassinger et al., 2009), plasmin, cathepsin D or a number of
matrix metalloproteinases (Barros et al., 2013; Fedarko et al.,
2004; Teti et al., 1998). In this work, we used OPNmix, probably
produced by endogenous proteolytic activity in milk (Christensen
et al., 2010; Sørensen et al., 1995). The principal components are
N-terminal phosphopeptides ending between residues 145 and
153 of the mature protein (Brian Christensen and Esben S. Søren-
sen, unpublished). In a previous work, this group of N-terminal
phosphopeptides was considered equivalent to OPN 1-149 (Holt
et al., 2009).
The bioﬂuids were prepared by a simple mixing method.
Aliquots of stock solutions were added slowly, with stirring, water
ﬁrst, followed by all the other ingredients apart from the phos-
phate salts. In addition to the components listed in Table 1, a pre-
servative, 1.5 mM sodium azide was added. The ﬁnal pH was
reached by adding aliquots of stock phosphate salt solutions of dif-
ferent basicity, usually 100 mM mono-hydrogen or di-hydrogen
sodium phosphates. For the experimental determination of stabil-
ity diagrams, solutions were made up over a range of phosphopep-
tide concentrations and pH. The solutions were examined at
regular intervals for up to 9 months to detect the onset and devel-
opment of an obvious, copious, precipitate. When ﬁrst formed, the
ACP precipitate occupies most of the volume of the solution but it
consolidates and settles over time.
2.6. Preparation of amorphous calcium phosphate nanoclusters
sequestered by osteopontin peptides
Nanoclusters at a higher concentration were also prepared by
the simple mixing method for small-angle neutron and elastic light
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22 mM calcium, 20 mM Pi, 1.5 mM sodium azide, ionic strength
78 mM, pH 7.0. Assuming that OPNmix has the same ion binding
properties as OPN 1-149, the equilibrium aqueous solution has a
free calcium ion concentration of 0.5 mM and, on average, each
phosphopeptide is attached to the calcium phosphate through only
one of its three phosphate centres. A solution was also made up at
a nominal 41% D2O to provide an approximate match point for the
OPNmix. A neutron transmission measurement established that
the actual D2O concentration was 39%. Samples were allowed to
equilibrate for at least 14 days before performing the scattering
measurements.
2.7. Neutron scattering
Neutron scattering measurements were made at 24 C on the
small-angle neutron diffractometer D33 ((Dewhurst, 2008, 2012)
at the Institut Laue-Langevin, Grenoble. Prior to each measure-
ment, samples containing 30 mg OPNmix ml1 were ﬁltered
through a 0.2 lm Sartorius syringe ﬁlter into Hellma quartz cells
of 1 mm optical path length. Scattering curves were recorded using
a ﬁxed incident neutron wavelength of 0.6 nm and wavelength
spread of 10%. A Guinier plot was made of the small-angle neutron
scattering in the scattering wave vector (q) range 0.0408–
0.1281 nm1 (q ¼ 4p sinðhÞ=k where k is the neutron wavelength
and 2h is the scattering angle). Data satisfying the condition
qRg 6 1were ﬁtted to a straight line to recover the value of the
radius of gyration, Rg.
2.8. Elastic light scattering
Experiments were performed on a CGS-3 Compact Goniometer
System (ALV, Langen, Germany) using a 22 mW He–Ne laser oper-
ating at 632.8 nm. The sample was diluted 500-fold with a buffer
which matched its ultraﬁltrate with respect to pH, ionic strength
and salt composition so that the solvent and free ion activities re-
mained constant during dilution. It contained 0.83 mM calcium
and 10.86 mM Pi.. Prior to measurement, the sample and dilution
buffer were ﬁltered through a Sartorius syringe ﬁlter of 0.2 lm
porosity into a QS cylindrical cell with an optical path length of
8 mm (Hellma, Mullheim, Germany). Measurements were made
at scattering angles between 30 and 150 in intervals of 10 at a
temperature of 24 C. After subtracting the dilution buffer scatter-
ing, the radius of gyration of the OPNmix nanoclusters in 0% and
39% D2O was recovered from the slope of a Guinier plot.
2.9. Dynamic light scattering
Dynamic light scattering measurements were made using a
Dynapro 801 TC instrument (Protein Solutions Inc., Lakewood, NJ,
USA) at 25 C. Artiﬁcial urine samples containing 0.2 mg OPNmix
ml1 were ﬁltered through aWhatman Anotop 10 ﬁlter with a pore
size of 0.2 lm. Correlation functions were inverted to give an
intensity weighted distribution of hydrodynamic radii using the
singular value decomposition method of Laplace transformation,
implemented in the DynaLS software (Alango Technologies Ltd.,
Tirat Carmel, Israel).3. Results
3.1. Size and structure of calcium phosphate nanoclusters formed with
OPNmix
The small-angle neutron and elastic light scattering results are
shown as Guinier plots in Fig. 2. The elastic light scatteringmeasurements yielded radii of gyration for the OPNmix nanoclus-
ters in 0% and 39% D2O of 24.5 ± 0.3 nm and 24.5 ± 0.48 nm,
respectively.
The small-angle neutron scattering Rg in 0% D2O was
19.5 ± 0.36 nm which may be compared with the Rg of
20.5 ± 0.1 nm for OPN 1-149 nanoclusters determined by small-an-
gle X-ray scattering (Holt et al., 2009). The small-angle neutron
scattering measurement in 39% D2O, close to the protein match
point, gave a lower Rg of 17.5 ± 0.51 nm, conﬁrming that the
nanoclusters have a core of calcium phosphate and a thin outer
shell, or corona, of OPNmix peptides. Indeed, the results of this
small-angle neutron scattering investigation on OPNmix nanoclus-
ters appear to be in good agreement with a model for OPN 1-149
nanoclusters derived from small-angle X-ray scattering measure-
ments (Holt et al., 2009).
Some differences in the value of the radius of gyration are to be
expected between elastic light scattering, small-angle neutron
scattering and small-angle X-ray scattering because scattering de-
pends on different physical properties (refractive index, neutron
scattering length density or electron density, respectively) in the
core and shell. Additional small-angle neutron scattering studies
on a complex made with a single OPN peptide are in progress
and will be combined with molecular weight and other measure-
ments to enable a more detailed model of the structure to be built.3.2. Evidence of calcium phosphate sequestration in milk, blood serum
and stimulated saliva
These natural bioﬂuids were examined to see if they exhibited
an invariant ion activity product and if so, whether it was equal
to a known KS (S = 1). The widest possible range of compositional
variation is desirable to test whether the calculated ion activity
products are, indeed, invariant. To achieve this, individual bovine
milk samples from healthy animals in early, middle and late lacta-
tion and individual cows with mastitis were examined. Published
blood serum compositional data from healthy individuals (Walser,
1961) and from individuals with an abnormal electrolyte balance
due to various clinical conditions (Walser, 1962) were analysed.
Published compositional data on the composition of individual
samples of human stimulated saliva were also analysed (Grøn,
1973b).
Fig. 3a–c demonstrate that the pH and Pi concentrations in each
of these bioﬂuids can vary considerably among the individuals
sampled. There was a similar variation in calcium. The mean (stan-
dard deviation), minimum and maximum mM concentrations of
ultraﬁltrate calcium in the bovine milks were 9.19 ± 1.77, 5.96
and 15.04. In the human sera the values were 1.44 ± 0.35, 0.74
and 2.64, respectively, and in the human stimulated salivas
0.77 ± 0.22, 0.39 and 1.28, respectively. In Fig. 3d–f, the individual
saturation indices are plotted as a function of pH, although any
other compositional variable could have been chosen. All the ﬂuids
were, as expected (Glinkina et al., 2004; Grøn, 1973a; Holt, 1982;
Larsen and Pearce, 2003; Lyster, 1981; May et al., 1977), highly
supersaturated with respect to hydroxyapatite and the ion activity
product values are positively correlated with pH. In spite of the
considerable compositional variation, saturation indices of ACP-2
and sequestered ACP fall in a narrow band and are close to being
invariant but all three ﬂuids are clearly supersaturated in ACP-2.
Bovine milk is close to saturated with respect to the ACP seques-
tered by casein phosphopeptides (Little and Holt, 2004). Blood ser-
um and stimulated saliva are close to saturation or slightly
undersaturated with respect to the OPNmix form of sequestered
ACP. The pKS in stimulated saliva was 9.26 ± 0.35 compared to
9.27 ± 0.13 for blood serum and 9.12 ± 0.05 for ACP sequestered
by OPNmix (Holt et al., 2009).
Fig. 2. Guinier plots of the small-angle neutron scattering and elastic light scattering of OPNmix nanoclusters in 0% and 39% D2O. (a) small-angle neutron scattering data and
linear ﬁts to the experimental points satisfying the criterion qRg 6 1. (b) Elastic light scattering data and linear ﬁts to all the experimental points.
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is clear, even in the samples showing extreme compositional vari-
ation, such as those originating from individuals with clinical dis-
orders. Thus, the serum samples from individuals with the
clinical conditions of hypercalcaemia or hyperphosphataemia ap-
pear to be no more supersaturated, on average, than the samples
from healthy individuals, even though these conditions are associ-
ated with coronary artery calciﬁcation.
Data on the pH and state of saturation of ultraﬁltrates from a
limited number of samples of resting parotid saliva (Grøn,
1973a,b) indicate that this ﬂuid is more acidic than stimulated sal-
iva. These samples were found to be undersaturated with respect
to ACP-2 and sequestered ACP but were variable in their state of
supersaturation with respect to hydroxyapatite (data not shown).
The absence of a well-deﬁned saturation index in resting saliva
may mean that this bioﬂuid is moving towards a state of equilib-
rium with the tooth enamel, possibly as a result of a tooth miner-
alisation process.
3.3. Calculated stability diagrams for bioﬂuids
Fig. 4 shows the stability diagrams calculated for the average
composition of human and bovine milks, human urine from non-
stone-forming individuals, human stimulated saliva and human
serum.
In most milks, the sequestration of ACP by casein is one of the
most important equilibria and it has to be taken into account in
any model of ion speciation. (Holt, 2004; Holt et al., 2009; Little
and Holt, 2004). The calculations for human milk follow the prin-
ciples applied to cows’ milk (Holt, 2004). However, the number
of phosphate centres in human milk casein differs from that in bo-
vine casein because of different mole fractions of the individual
caseins and differences of primary structure. The mole fractions
of the individual caseins were calculated as previously described
(Holt and Carver, 2012). Because of incomplete phosphorylation
only a fraction of each potential phosphate centre is phosphory-
lated. For example the single phosphate centre of human b-casein
comprises 6 phosphoforms containing 0–5 phosphoseryl residues
(Poth et al., 2008). The 3P, 4P and 5P phosphoforms have the struc-
ture required of a phosphate centre and comprise, on average,
47.16% of the total (Kroening et al., 1998). Accordingly human b-
casein has 0.47 phosphate centres per mole. The human aS1-casein,
like the bovine orthologue, has two phosphate centres if fully phos-
phorylated, but like the human b-casein a number of different
phosphoforms are detectable (Poth et al., 2008). Assuming a
similar degree of phosphorylation at each phosphate centre to that
seen in human b-casein, the mole fractions with 0, 1 and 2phosphate centres are calculated to be 0.28, 0.50 and 0.22, respec-
tively. For human whole casein, calculation gives 0.44 phosphate
centres per average mole of casein.
In Fig. 4a the calculated values of pHcrit and the stability bound-
ary are shown for bovine and human milks. Both of these milks
have a physiological pH of 6.7–6.8 but whereas the pHcrit of human
milks lies above the physiological pH, the pHcrit of bovine milk is
well below the physiological pH. As a result, human milk contains
no sequestered ACP whereas bovine milk contains a high concen-
tration of sequestered ACP. At pH 6.7, on average, 90% of the bovine
casein phosphate centres are complexed to ACP leaving a small ex-
cess of free phosphate centres. In contrast to bovine milk, human
milk is poorly buffered by phosphate so that the loss of bicarbonate
by equilibration with air increases the pH to about 7.2 so that a
small concentration of sequestered ACP is predicted from the cal-
culations and has been conﬁrmed experimentally.
Fig. 4b shows the stability diagram for the average composition
of saliva, blood serum from healthy individuals and urine from
non-stone-forming subjects (Grøn, 1973b; Robertson et al., 1968;
Walser, 1961). The composition of saliva is very variable and
dependent on the method of collection. Even when care is taken
to preserve the bicarbonate-carbon dioxide equilibrium, the pH
of resting saliva is appreciably less than that of stimulated saliva
and the Pi concentration may be twice as high (Gal et al., 2001;
Grøn, 1973b; Hay et al., 1982; Larsen and Pearce, 2003; Schipper
et al., 2007). Ultraﬁltration demonstrates that an appreciable frac-
tion of the total calcium and Pi does not pass through membranes
with molecular weight cut-off of 10,000 Da, or less. The proportion
increased as the pore size of the membrane decreased and most of
the non-ultraﬁlterable fraction was not associated with proteins
(Grøn, 1973a; Hay et al., 1982). The physiological pH of 7.35 is
appreciably above pHcrit, suggesting that the observed concentra-
tion of retained Pi could be in some form of sequestered calcium
phosphate. The stability diagram calculated for the average com-
position of stimulated saliva is shown in Fig. 4b, assuming that
complexes are formed with the composition and solubility of
OPN nanoclusters even though the OPN concentration of saliva is
very low (Schipper et al., 2007). The stability boundary at the phys-
iological pH corresponds to a phosphate centre concentration of
66.6 lM. Although statherin and the acidic and basic proline-rich
proteins of saliva can be phosphorylated (Messana et al., 2008; Vit-
orino et al., 2010) and will bind to calcium phosphate, the main sal-
ivary proteins do not contain any phosphate centre sequences. It is
therefore most unlikely that the non-ultraﬁlterable component of
stimulated saliva is stabilised by a phosphate centre-containing
phosphopeptide. Surprisingly, the salivary proteins have an effect
very closely similar to that of OPNmix in sequestering ACP.
Fig. 3. Compositional variation and Log(saturation indices) in ultraﬁltrates of bovine milk, human blood and stimulated saliva (Grøn, 1973b; Holt, 2004; Holt et al., 1981;
Walser, 1961, 1962; White and Davies, 1958). (a) Illustration of the natural variations in Pi and pH in milk ultraﬁltrates from individual healthy cows in early (black), mid
(green) or late (blue) lactation and for cows with mastitis (red). (b) Illustration of the natural variations in Pi and pH in human blood ultraﬁltrates from healthy subjects
(green), individuals with hypercalcaemia (red) or renal disease (black). (c) Illustration of the variation in Pi composition of stimulated parotid (black), whole (green) and
submaxillary (red) saliva ultraﬁltrates. (d) Log(saturation indices), logS, of the bovine milk ultraﬁltrate samples shown in Fig. 3a. (e) Log(saturation indices) of the human
serum ultraﬁltrate samples shown in Fig. 3b. (f) Log(saturation indices) of the stimulated human saliva ultraﬁltrate samples shown in Fig. 3c.
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is retained by Visking or other membranes (Toribara et al., 1957;
Trechsel et al., 1976; Walser, 1961, 1962). This means that the Pi
is perhaps nearly all in solution rather than sequestered as ACP.
The stability diagram shows that at the average physiological pH
of 7.57 (Walser, 1961), blood serum is slightly undersaturated with
respect to the KS of OPNmix nanoclusters.
3.4. Experimental stability diagrams for artiﬁcial bioﬂuids
The thermodynamic model of nanocluster formation suggests
that many different types of bioﬂuid can exist in a stable state at
or around their physiological pH and above, provided there is a
high enough concentration of a competent sequestering phospho-
peptide. Experimental testing of the theory has used simpliﬁed
artiﬁcial blood serum, stimulated saliva or urine containing either
b-casein 1-25, NaCPP or OPNmix. Because b-casein 1-25, is fully
phosphorylated, the molar concentration of phosphate centres is
well deﬁned, allowing a quantitative comparison with the theory.
The concentration of phosphate centres in the phosphopeptide
mixtures NaCPP and OPNmix is not known so the comparison with
theory is only qualitative. The use of either NaCPP or OPNmix to
stabilise artiﬁcial bioﬂuids has the advantage that both are avail-
able commercially in larger quantities at a much lower cost than
the pure peptide. The fact that stabilisation can be achieved with
peptide sequences having no similarities other than phosphate
centres is an argument in favour of the theory that phosphate cen-
tres are the essential ingredients.
Fig. 5a shows that there is close agreement of theory with
experiment for artiﬁcial blood serum containing the b-casein 1-
25 over the whole stability boundary. The positions of the stable
and unstable regions are in line with the serum stability boundary
shown in Fig. 4b. Fig. 5d shows the results for the artiﬁcial saliva
after 3 weeks with the approximate position of the theoreticaland actual stability boundaries marked by dashed lines. Between
the two lies a region of metastability in which a copious precipitate
failed to form. Nevertheless, when the samples were re-examined
after approximately 9 months storage at room temperature, each
of the samples in the metastable region had developed a very small
amount of precipitate.
In Fig. 5e the appearance of the artiﬁcial urine samples recorded
after 3 days and after 9 months are given to demonstrate that at
any phosphopeptide concentration the amorphous precipitate
was detected ﬁrst at the highest pH but took many weeks to form
close to the stability boundary. At the highest OPNmix concentra-
tion studied, all the solutions were metastable for several days and
in some cases precipitation did not occur for months. The samples
with the highest OPNmix concentration proved suitable for a light
scattering study. On day 2, before precipitation began, all the solu-
tions appeared clear but the total scattered intensity increased
sharply with pH above 7.4. In Fig. 5f the apparent, intensity-
weighted, distributions of hydrodynamic radius are shown for 6
of the samples after ﬁltration through a syringe ﬁlter of 0.2 lm
porosity. Up to pH 7.4 there were two peaks in the size distribu-
tion. One peak had a hydrodynamic radius of about 3.5 nm, which
is the hydrodynamic radius of OPN 1-149-type peptides. Larger
particles of 100 nm or more were also detected when a 0.4 lm ﬁl-
ter was used but because of the intensity weighting they com-
prised only a very small weight fraction of the solute. For the
same reason it can be concluded that most of the OPNmix in these
samples is in the form of free peptides with the remainder present
as particles with a hydrodynamic radius of about 20 nm, compara-
ble in size to the nanoclusters formed from OPN 1-149. Two sam-
ples at pH 8.0 and 8.2 were examined by light scattering after
ﬁltration through a 0.2 lm syringe ﬁlter but a third at pH 8.5
blocked both the 0.2 lm and 0.4 lm syringe ﬁlters and could not
be measured. The high pH samples showed a stronger total scat-
tered intensity and a quite different distribution of hydrodynamic
Fig. 4. The calculated stability boundaries for the average composition of bioﬂuids given as a function of pH and casein/phosphate centre concentration, with stable, unstable
or metastable regions and pHcrit as in Fig. 1. (a) Stability diagrams for bovine and human milk based on the average milk compositional data of a herd of Ayrshire cows (Holt,
2004; White and Davies, 1958) and the average composition of 21 samples of human breast milk during the ﬁrst 16 weeks of breast feeding (Holt, 1993). Calculations used
the solubility constant and composition of casein nanoclusters. (b) The corresponding stability diagrams for the average composition of stimulated saliva (Grøn, 1973b), urine
from non-stone-forming individuals (Robertson et al., 1968) and blood serum of healthy individuals (Walser, 1961). Calculations assumed a sequestered form of ACP with the
composition and solubility constant of the complex formed by OPNmix (Holt et al., 2009).
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detected in the intensity weighted distribution which showed
either a single peak at a hydrodynamic radius of about 10 nm or
a similar peak with a higher shoulder corresponding to a radius
of about 30 nm. The three high pH samples were unstable and
each, subsequently, formed a copious amorphous precipitate.4. Discussion
4.1. Stable, metastable and unstable bioﬂuids
A solution of ACP nanoclusters is thermodynamically stable
provided three conditions are satisﬁed. These are that (a) no fur-
ther ACP can form (i.e. the solution is undersaturated with respect
to a bulk phase of ACP), (b) the sequestered ACP cannot mature
into a more crystalline phase and (c) the solution is not in contact
with a crystalline calcium phosphate. We now consider each of
these conditions.4.1.1. Undersaturation with respect to ACP
In Appendix A, the theory of ACP sequestration by phosphate
centre-containing phosphopeptides is generalised to describe the
formation of stable, unstable and metastable bioﬂuids containing
acidic peptides in general. The fundamental principle is that a
sequestering peptide can bind to a nucleus of ACP as it forms from
a solution to reduce the total free energy at the interface. In the ab-
sence of a sequestering peptide, the surface free energy of a nu-
cleus is positive and the nucleus can only form from a solution
that is supersaturated with respect to the bulk phase. However if
the total surface free energy is negative because of the number
and strength of binding peptides, an equilibrium complex can form
spontaneously from a solution that is undersaturated with respect
to the bulk ACP phase. No further ACP can form and because
hydroxyapatite cannot normally form except by maturation of an
initial ACP phase, the solution is thermodynamically stable even
if it is calculated to be supersaturated with respect to that phase.
We have found empirically that peptides containing a phosphate
centre can form thermodynamically stable solutions of seques-
tered ACP. Peptides containing fewer than three phosphorylated
residues can, in principle, form equilibrium complexes (Appendix
A) but thermodynamically stable complexes formed by suchphosphopeptides have not yet been observed (Aoki et al., 1992;
Little and Holt, 2004).4.1.2. Stable sequestered ACP
An additional factor that can lead to colloidal instability and
precipitation is the possible maturation of the ACP in its complex
with the sequestering or binding phosphopeptide. This is because
a crystalline particle, with a lattice energy contribution to its free
energy of formation cannot easily be prevented from growing by
more weakly interacting phosphopeptides. According to the theory
of nanocluster formation, the core radius increases as the free en-
ergy of sequestration becomes more negative. The largest known
casein phosphate centres, and hence, possibly, the phosphate cen-
tres with the highest binding afﬁnities contain up to 8 actual or po-
tential phosphoseryl residues (Holt et al., 2009) but some bone and
dental peptides can contain much longer phosphorylated se-
quences. There is some evidence that sequestered ACP can vary
in composition and hence can mature to some extent. In the casein
micelles of bovine milk and in equilibrium complexes formed by
casein phosphopeptides, 50% or more of the Pi in the sequestered
ACP is HPO24 (Holt, 1997; Little and Holt, 2004) whereas in meta-
stable complexes formed by a minimum proportion of casein phos-
phopeptides (Cross et al., 2005) and in equilibrium complexes
formed by OPN 1-149 (Holt et al., 2009), the core ACP is all formed
from PO34 . Thus, the maturation of ACP can be stopped at different
points depending on the nature of the sequestering phosphopep-
tide and its concentration. Poorly crystalline calcium phosphate
can be detected in milk after prolonged heating (Nelson et al.,
1989; Thachepan et al., 2010) but it is not clear whether seques-
tered ACP has matured or whether additional, unsequestered,
ACP has formed from the continuous phase during heating, and
then matured.4.1.3. Contact with a crystalline calcium phosphate
A solution of sequestered nanoclusters is potentially unstable
when brought into contact with hydroxyapatite or a similar crys-
talline calcium phosphate phase because the crystals will tend to
grow at the expense of the nanoclusters and can only fail to do
so if the growth sites are blocked by, for example, adsorbed phos-
phopeptides such as OPN (Gericke et al., 2005a; Hunter et al.,
2010). Conversely, a solution of sequestered nanoclusters can act
Fig. 5. Stability diagrams of artiﬁcial bioﬂuids stabilised by phosphopeptides. The approximate experimental stability boundaries for artiﬁcial sera containing the
phosphopeptide mixtures are indicated by a dashed line. Open circles correspond to a single phase solution and ﬁlled circles are for solutions containing a copious precipitate.
(a) Stabilisation of serum by bovine b-casein 1–25. The theoretical boundary line separates the stable from the two-phase region. (b) Stabilisation of serum by NaCPP. (c)
Stabilisation of serum by OPNmix. (d) Stabilisation of artiﬁcial stimulated saliva by OPNmix. (e) Stabilisation of artiﬁcial urine by OPNmix. At each OPNmix concentration,
observations were recorded after 3 days and 9 months and are slightly offset. (f) Intensity-weighted size distributions in the artiﬁcial urine samples at the highest OPNmix
concentration on day 2. Plots are offset vertically for clarity.
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crystal growth.4.1.4. Metastable solutions
Thermodynamically stable solutions of calcium phosphate are
undersaturated with respect to bulk ACP even though they may
be supersaturated with respect to HA, whereas thermodynamically
unstable solutions are supersaturated with respect to both the ini-
tial phase and HA. A metastable solution is one that is thermody-
namically unstable with respect to the initial phase but slow toprecipitate. One reason for slow precipitation may be a low density
of peptides adsorbed on ACP in its early stages of formation. The
peptides may provide a steric or electrostatic barrier, slowing
down the further aggregation of the ACP particles.4.1.5. Importance of ACP sequestration in bioﬂuids
Thermodynamically stable ﬂuids have been described where
the sequestering peptide contains a phosphate centre and is pres-
ent in stoichiometric excess of the number of moles of ACP formed
by the ﬂuid. Calcium phosphate nanoclusters sequestered by a
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radius and constant average composition (Holt et al., 1996, 2009,
1998; Little and Holt, 2004). In this paper we have shown how arti-
ﬁcial bioﬂuids can be stabilised using essentially the same theory
as applies in milk and OPNmix nanocluster solutions. Stability
boundaries can be calculated for any given bioﬂuid composition
(Fig. 4) and the position of the calculated boundary for human ser-
um, urine and stimulated saliva corresponds well with experimen-
tal observations (Fig. 5), although metastable stimulated saliva
solutions can persist for many weeks.
Notwithstanding the importance of the binding of single ions to
phosphopeptides, the key factor affecting the stability of bioﬂuids
is the sequestration of ACP. The maturation of the sequestered
ACP in milk is completely inhibited by the strong binding of phos-
phate centre-containing casein sequences and the sequestered ACP
reaches equilibrium with the continuous phase. In this important
respect the model for milk differs from the SEQUIL equilibrium
model for urine (Ashby and Györy, 1997; Ashby et al., 1999; Györy
and Ashby, 1999) because the sequestered ACP is much more sol-
uble than hydroxyapatite so the serum concentrations of calcium
and phosphate ions at equilibrium are much higher.
For a bioﬂuid to be stable in a physiological context it must be
able to deal with temporary departures from homeostasis such as
ﬂuctuations in composition or pH that allow ACP nuclei to form. If
the concentration of phosphate centres in a bioﬂuid is above the
minimum then the bioﬂuid has some capacity to cope with the
spontaneous generation of ACP caused by such ﬂuctuations. The
peptides can sequester the ACP nuclei as soon as they form. In this
situation, the reversible nature of the complex of sequestered ACP
with phosphopeptides is important because the transient com-
plexes can readily dissociate when homeostasis is restored. In
the absence of the peptides the ACP nuclei could mature into a
more stable and less soluble deposit that persists after the ﬂuctu-
ation disappears.
Fluctuations from equilibrium, in the absence of phosphopep-
tides or in the presence of only a weakly-binding phosphopeptide
or unphosphorylated peptide such as poly-Asp (Gower, 2008; Ols-
zta et al., 2007), could initiate an irreversible process leading to
physiological mineralisation of collagen ﬁbrils in bone or patholog-
ical, highly insoluble, ectopic deposits in soft tissues and bioﬂuids.
4.2. Is ACP sequestration by phosphoproteins of general physiological
importance?
4.2.1. ACP sequestration in milk
The sequestration of ACP by caseins in bovine milk is well
established experimentally and provides the basis for a quantita-
tive model of the speciation of ions and partition of salts in this
bioﬂuid (Holt, 2004). The phenomenon of ACP sequestration by
casein is consistent with the huge range of variation in casein, cal-
cium and phosphate concentrations in the milk of mammals (Holt,
1983; Holt and Jenness, 1984; Jenness and Holt, 1987; Oftedal,
2012). Caseins actually evolved before lactation (Kawasaki et al.,
2011; Lefèvre et al., 2010) from other secreted calcium (phos-
phate)-binding phosphoproteins involved in many aspects of the
control of biomineralisation. Their role in milk may simply be an
adaption of a closely related antecedent function in the control of
some aspect of biomineralisation (Holt and Carver, 2012).
4.2.2. ACP sequestration in soft tissues and other bioﬂuids
OPN and derived peptides are widely distributed in bioﬂuids as
well as in soft and mineralised tissues. The OPN sequence includes
a number of phosphate centre-type sequences, longer phosphory-
lated sequences in the C-terminal half and acidic, Asp-rich,
sequences. The OPN 1-149 peptide and cognate sequences have
the integrin-binding RGD motif near their C-terminus. Thus, OPNpeptides are capable of acting in a number of different but biolog-
ically important ways (Mazzali et al., 2002). Amorphous calcium
phosphate nanoclusters sequestered by OPN 1-149 have been
characterised experimentally. Moreover, the formation of calcium
phosphate nanoclusters is not restricted to milk-like salt concen-
trations or pH (Little and Holt, 2004). Furthermore, in this work
we have demonstrated transient, nanocluster-like, particles in
unstable artiﬁcial urine samples (Fig. 5f). Examination of previ-
ously published compositional data on ultraﬁltrates of saliva and
blood demonstrate an invariant ion activity product closely similar
in form and magnitude to that found in nanocluster solutions
formed with OPNmix (Fig. 3). Thus, nanoclusters of ACP should
be present in stimulated saliva and in serum, albeit possibly at
such a low concentration in serum that they would be difﬁcult to
detect. Notwithstanding their low concentration, quantitative pre-
dictions of the stability to precipitation of blood serum, saliva and
urine, and probably many other bioﬂuids, are now possible by
adaptation of the thermodynamic model used successfully to de-
scribe milk.
In urine from non-stone-forming individuals, the pH is usually
below pHcrit, but some types of urinary infections can raise the
pH and cause calcium phosphate to precipitate. In stimulated sal-
iva, sequestered calcium phosphate is present but may be in the
form of unstable protein complexes formed by Pro-rich salivary
proteins (Rykke et al., 1997a,b; Young et al., 1999). Moreover the
complexes are in contact with tooth surfaces and may be required
for the remineralisation of lesions. The globular complexes may re-
sult from the mixing of parotid, submandibular and sublingual
secretions and are thought to form the primary enamel pellicle
(Young, 1999). Notwithstanding the instability of the globules, in
stimulated saliva the invariant ion activity product is very similar
to that in blood serum and thermodynamically stable solutions
of OPNmix nanoclusters.
The concentration of phosphopeptides required for stability
depends upon the nature of the bioﬂuid. For blood serum and ur-
ine, where pHcrit is close to or below the physiological pH, the con-
centration can be sub-lM. For human saliva and some milks it can
be sub-mM and for rapidly growing species that secrete stable,
high-calcium milks, it can be as high as 4 mM (Holt and Carver,
2012). In milk, the phosphate centres are mainly from caseins
whereas in blood serum, OPN, Fetuin-A, secreted phosphopro-
tein-24 and others may all contribute (Price et al., 2003).
There are relatively few examples of bioﬂuids other than milk
where the molar concentration and degree of phosphorylation of
sequestering proteins are known. In healthy individuals, plasma
OPN is typically about 50–60 mg/l but serum levels may be 4–
5-fold lower (Lanteri et al., 2012; Wendelin-Saarenhovi et al.,
2011). Serum fetuin A concentrations are approximately 1000-
fold lower (Fiore et al., 2007). Circulating levels of these
phosphopeptides are raised in many patients with generalised
inﬂammatory conditions or cardiovascular lesions (Giachelli
et al., 1995). Vascular calciﬁcation is associated with elevated lev-
els of serum calcium, Pi and OPN. It increases with age and is pre-
valent in subjects with diabetes or advanced renal disease.
Elevated calcium and Pi may act synergistically to stimulate a
transition in the vascular smooth muscle cell phenotype and
function so that the transformed cells make a type of osteoid.
OPN, however, appears to inhibit vascular calciﬁcation (Jono
et al., 2000; Lau et al., 2010; Shanahan et al., 2011). In Fig. 3e
it is demonstrated that serum samples all have about the same
saturation index with respect to sequestered ACP, irrespective
of their calcium or Pi concentration, suggesting that serum satu-
ration may not have a primary role in the induction of vascular
calciﬁcation. What the theory shows, however, is the importance
of an excess concentration of phosphate centres and, for serum,
this translates to an excess of OPN phosphopeptides.
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predominates but Fetuin-A is also present. The concentration of
uropontin can vary from <1 to >20 mg l-1 (Asplin et al., 1998;
Min et al., 1998; Thurgood et al., 2008). Lower levels of free uro-
pontin and greater degrees of proteolysis by serine proteinases
are associated with stone formation but some of the uropontin is
bound to the stones (Bautista et al., 1996; Nishio et al., 2000). In
saliva, non-phosphate centre-containing phosphopeptides pre-
dominate, including statherin and acidic and basic proline-rich
phosphopeptides (Madapallimattam and Bennick, 1990; Messana
et al., 2008; Schipper et al., 2007; Vitorino et al., 2010).
4.2.3. ACP sequestration in hard tissues
The major non-collagenous phosphoprotein of the extracellular
matrix of bone is OPN, which contains both phosphate centre-like
sub-sequences and longer phosphorylated sequences. Experiments
in vitro with a number of phosphopeptides, including OPN, have
shown that the balance between inhibition and nucleation of
calcium phosphate appears to depend on the phosphopeptide
concentration, its degree of phosphorylation and the extent of pro-
teolytic processing (Boskey et al., 2010, 2012). In our experimental
work we have shown that inhibition depends on the molar ratio of
precipitating ACP to sequestering phosphopeptide and in theory
we propose that the maturation of sequestered ACP depends on
the free energy of sequestration and length of phosphorylated
sub-sequences. Proteins such as OPN can inhibit the formation of
ACP by means of their phosphate centre-type sequences and we
suggest that the longer phosphorylated sequences can act as nucle-
ators of ACP and promoters of its maturation into more crystalline
phases. If the rate of the latter reaction is slow compared to the for-
mer then nucleation can predominate at a high molar ratio of pre-
cipitating ACP to OPN where inhibition by sequestration is
ineffective and inhibition predominates at lower molar ratios of
precipitating ACP to OPN.
Recent in vitro experiments have demonstrated that calcium
phosphate nanoparticles complexed to a low molar ratio of OPN-
mix can lead to intra-ﬁbrillar mineralisation of collagen with
hydroxyapatite (Rodriguez et al., 2013).
4.3. Therapeutic and prophylactic applications of artiﬁcial bioﬂuids
stabilised by phosphoproteins or phosphopeptides
Artiﬁcial sera for therapeutic and prophylactic use should have
a physiological pH and concentrations of both calcium and Pi that
approximate average values in healthy individuals. The formula-
tions should include a low concentration of a sequestering phos-
phopeptide to ensure that precipitation of calcium phosphate
does not occur. They offer certain advantages over conventional
formulations that are widely used in kidney and peritoneal dialy-
sis, wound and joint irrigation, and as replacements for blood ser-
um or saliva. For example, they can match their natural
counterparts in ionic strength, osmolality, the concentrations of
major salts, including both calcium and phosphate, pH and satura-
tion so that homeostasis is maintained. With these improved arti-
ﬁcial bioﬂuids, soft tissues should not mineralise and hard tissues
should not demineralise.
In this work the artiﬁcial bioﬂuids were formulated without any
contribution from bicarbonate to the buffering of pH. This was sim-
ply a matter of convenience so that the calcium phosphate equilib-
ria could be studied at constant pH without using environmental
controls to maintain bicarbonate and CO2 equilibria. The artiﬁcial
bioﬂuids were also simpliﬁed by the omission of urate and oxalate
so that the precipitation of uric acid or calcium oxalates did not oc-
cur to complicate the calcium phosphate precipitation phenomena
under study. There is no reason, however, why these and other nat-
ural constituents could not be added.Acknowledgments
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Amorphous calcium phosphate may bind different types of pep-
tides to form either reversible, thermodynamically stable, com-
plexes or irreversible, unstable (or metastable) complexes (Fig. A1).
The Gibbs free energy of formation of an equilibrium complex
between ACP and a stoichiometric excess of a sequestering phos-
phopeptide, (DGo), can be divided into the free energy of formation
of the core of ACP (DGcore) and the free energy of sequestration of
the ACP by a shell of the phosphopeptide (expressed per mole of
phosphopeptide, DGseq), to form a core-shell structure (Holt
et al., 2009; Little and Holt, 2004). For a complex containing imoles
of calcium phosphate sequestered by a complete shell containing j
moles of phosphopeptide.
DGo ¼ iDGcore þ jDGseq ðA1Þ
If the number of sequestering phosphopeptides is proportional
to the surface area of a spherical core
DGo ¼ iDGcore þ ki2=3DGseq=A ðA2Þ
where k ¼ ð36pV2ACPÞ
1=3
, A is the core surface area occupied by each
phosphopeptide and VACP is the molar volume of the empirical
formula of the ACP. Using the Gibbs-Thompson equation for a
monomer-multimer equilibrium, the equilibrium average radius
of the core of the complex is then given by (Holt et al., 2009)
rcore 
2kDGseq
3AkDGcore
 
3VACP
4p
 1=3
¼ 2kDGseq3ART ln ða1=asÞ
 
3VACP
4p
 1=3
ðA3Þ
where a1 is the activity of the ACP monomer in the solution contain-
ing the complex, as is the activity of the ACP monomer in a solution
saturated with respect to the bulk ACP phase. Note that if there is a
spontaneous reaction between the phosphopeptide and the core
surface then DGseq is negative and hence a1 < as. In other words, a
solution containing the equilibrium complexes is undersaturated
with respect to the bulk phase of ACP. Even though the solution re-
mains supersaturated with respect to more crystalline phases, these
cannot form because the initial phase cannot form. Thus, solutions
containing sequestered ACP are thermodynamically stable but only
if the sequestered ACP cannot mature into a more crystalline phase.
Eq. (A3) takes the same form as the critical size of a nucleus in
the description of homogeneous phase separation, originally devel-
oped by Volmer and Weber (Volmer and Weber, 1926). According
to their model, spontaneous ﬂuctuations from a supersaturated
phase are opposed by the interfacial tension of a nucleus, c. The
free energy of forming a spherical nucleus is then
Fig. A1. Biological consequences of ACP sequestration. If a bioﬂuid contains a
stoichiometric excess of a sequestering, phosphopeptide (e.g. phosphate centre-
containing peptides), a stable, reversible, equilibrium complex is formed. Hard
tissues in contact with the bioﬂuid remain mineralised and mineral deposits do not
form in soft tissues or the bioﬂuid. If the bioﬂuid produces an excess of ACP over the
sequestering phosphopeptide or if the peptide is only able to bind weakly, then a
metastable intermediate is formed. Nucleating peptides may contain long, strongly-
binding, phosphorylated sequences that bind ACP but allow it to mature. Whether
the binding is strong- or weak, nucleating peptides can sometimes localise a
metastable intermediate to speciﬁc sites such as collagen intra-ﬁbrillar spaces.
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Above a critical size, the nucleus will continue to grow and form
a bulk phase until equilibrium is established. The critical size is gi-
ven by
rnuc 
2kc
3DGcore
 
3VACP
4p
 1=3
¼ 2kc3ART ln ða1=asÞ
 
3VACP
4p
 1=3
ðA5Þ
However, in this case c is positive and hence nuclei can only
form from a solution which is supersaturated with respect to the
bulk phase of ACP (a1 > aS).
A generalisation from Eqs. and is possible in which the phos-
phopeptides are adsorbed to only a fraction, h, of the core surface.
The sequestration free energy is for a complete shell so in the inter-
mediate case this term is replaced by an adsorption free energy
which is a function of hDGads(h). The free energy of formation of
the complex is then
DGo ¼ iDGcore þ ki2=3½hDGadsðhÞ=Aþ ð1 hÞc ðA6Þ
And the equivalent expression for the equilibrium or critical ra-
dius, r⁄, is
r  2k½hDGadsðhÞ=Aþ ð1 hÞc3DGcore
 
3VACP
4p
 1=3
¼ 2k½hDGadsðhÞ=Aþ ð1 hÞc3RT ln ða1=asÞ
 
3VACP
4p
 1=3
ðA7Þ
The sum of the two terms in square brackets may be either po-
sitive, negative or zero. If it is zero or negative, equilibrium is
established and an excess of the sequestering phosphopeptide en-
sures that a bulk phase of ACP cannot form. If it is positive then the
solution remains supersaturated with respect to ACP, a metastable
complex is formed, but subsequently a bulk phase of ACP may pre-
cipitate and mature. The sequestering phosphopeptide may occupy
only a fraction of the core surface. This can happen if there are
unfavourable interactions between adsorbing peptides, if its cross
sectional area is greater than that of a binding site or if its concen-
tration, or intrinsic afﬁnity for the surface, is too low to occupy all
the potential binding sites.
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